SFX by Ex Libris Inc.

Title:	Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor
Source:	Nature [0028-0836] Lee, J E yr:2008

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	CÃÂtÃÂ, M. "Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection." Nature 477.7364 (2011): 344-348.
description	2.	Feldmann, H. "Ebola haemorrhagic fever." Lancet 377.9768 (2010): 849-862.
description	3.	Murin, Charles D. "Structures of protective antibodies reveal sites of vulnerability on Ebola virus." Proceedings of the National Academy of Sciences of the United States of America 111.48 (2014): 17182-7.
description	4.	Vladimir, N. Malashkevich M. "Core Structure of the Envelope Glycoprotein GP2 from Ebola Virus at 1.9- angstrom Resolution." Proceedings of the National Academy of Sciences of the United States of America 96.6 (1999): 2662-2667.
description	5.	Leung, D. "Structure of the Ebola VP35 interferon inhibitory domain." Proceedings of the National Academy of Sciences of the United States of America 106.2 (2009): 411-416.
description	6.	Leroy, Eric M M. "Fruit bats as reservoirs of Ebola virus." Nature 438.7068 (2006): 575-6.
description	7.	Sobarzo, A. "Persistent immune responses after Ebola virus infection." The New England journal of medicine 369.5 (2013): 492-493.
description	8.	Carette, Jan E. "Ebola virus entry requires the cholesterol transporter Niemann-Pick C1." Nature 477.7364 (2011): 340-343.
description	9.	Hoenen, T. "Ebola virus: unravelling pathogenesis to combat a deadly disease." Trends in molecular medicine 12.5 (2006): 206-15.
description	10.	Konduru, K. "Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice." Vaccine 29.16 (2011): 2968-77.
description	11.	LeDuc, J W W. "An introduction to Ebola: the virus and the disease." The journal of infectious diseases 179 Suppl 1.1 (1999): 170-176.
description	12.	Leung,, Daisy W., Kathleen C. "Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35." Nature Structural & Molecular Biology 17.2 (2010): 165-172.
description	13.	Leung, Daisy W. "Structural and Functional Characterization of Reston Ebola Virus VP35 Interferon Inhibitory Domain." Journal of molecular biology 399.3 (2010): 347-357.
description	14.	Olal, D. "Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus." Journal of virology 86.5 (2012): 2809-2816.
description	15.	Nabel, G J J. "Immunization for Ebola virus infection." Nature medicine 4.1 (1997): 37-42.
description	16.	Groseth, A. "The ecology of Ebola virus." Trends in Microbiology 15.9 (2007): 408-16.
description	17.	Weissenhorn, W. "Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain." Molecular cell 2.5 (1998): 605-616.
description	18.	Vander Heiden, Lewis G. "Understanding the Warburg effect: the metabolic requirements of cell proliferation." Science 324.5930 (2009): 1029-33.
description	19.	Wilson, J. "Vaccine Potential of Ebola Virus VP24, VP30, VP35, and VP40 Proteins." Virology 286.2 (2001): 384-390.
description	20.	Weik, M. "Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation." Journal of virology 76.17 (2002): 8532-9.